Biotech

All Articles

Pfizer, Valneva reveal lyme condition chance efficient for 2nd booster

.Pfizer and Valneva might have regarding pair of even more years to hang around prior to they produc...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Permit's dive into a discussion with Ayla Ellison, Strong Biotech Editor-in-Chief and Michelle Benz...

New records show how Bayer's asundexian failed to avoid strokes

.Bayer suspended the period 3 trial for its variable XIa prevention asundexian behind time in 2013 a...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own a number of sclerosis (MS) med tolebrutinib to the F...

Galapagos' stock up as fund presents intent to shape its evolution

.Galapagos is coming under extra pressure from capitalists. Having actually created a 9.9% concern i...

Cell- concentrated Sana scoops 1st CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable management hirings, firings...

Allist settles Jacobio $21M, landing part in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has actually purchased on its own a starring role in China's KRAS m...

ReNeuron leaving AIM exchange after overlooking fundraising target

.ReNeuron has actually participated in the long list of biotechs to leave London's purpose stock mar...

MBX declare IPO to take challenger to Ascendis in to phase 3

.MBX Biosciences has contributed to the recent flurry of IPO filings. The biotech, which submitted i...

FDA grows probe right into Lykos' MDMA tests: WSJ

.For Lykos Therapies and the company's potential MDMA-assisted therapy for trauma (POST-TRAUMATIC ST...